TruNorth Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
TruNorth Capital Management's AMGN Position: Q2 2025 in Review
TruNorth Capital Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 250 shares — an estimated $77.9K sold.
TruNorth Capital Management first reported a position in AMGN in Q1 2025 and held it in 1 quarter. The position peaked at $77.9K in Q1 2025. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- TruNorth Capital Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- TruNorth Capital Management sold 250 Amgen shares in Q2 2025, an estimated $77.9K.
- TruNorth Capital Management first reported a position in Amgen in Q1 2025 and held it in 1 quarter.
- TruNorth Capital Management's Amgen position peaked at $77.9K in Q1 2025.
- 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on TruNorth Capital Management's 13F filing for Q2 2025, filed 18 Jul 2025.